Literature DB >> 17418382

Phase I/II trial of intermittent subcutaneous IL-2 administration in pediatric patients with moderate immune suppression: results of Pediatric AIDS Clinical Trials Study 402.

Savita Pahwa, Petronella Muresan, John Sleasman, Terry Fenton, John Moye, Audra Deveikis, Diane Wara, Russ Van Dyke.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17418382     DOI： 10.1016/j.jaci.2006.12.674

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  3 in total

Review 1.  Pediatric HIV: the Potential of Immune Therapeutics to Achieve Viral Remission and Functional Cure.

Authors:  Stella J Berendam; Ashley N Nelson; Ria Goswami; Deborah Persaud; Nancy L Haigwood; Ann Chahroudi; Genevieve G Fouda; Sallie R Permar
Journal:  Curr HIV/AIDS Rep       Date:  2020-06       Impact factor: 5.071

2.  Role of common gamma chain utilizing cytokines for immune reconstitution in HIV infection.

Authors:  Savita Pahwa
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 3.  Secondary immunodeficiencies, including HIV infection.

Authors:  Javier Chinen; William T Shearer
Journal:  J Allergy Clin Immunol       Date:  2009-12-29       Impact factor: 10.793
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.